Charles River Laboratories International (CRL) EBT Margin Growth (1y) (2010 - 2026)
Charles River Laboratories International (CRL) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 617.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 948.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -115.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 163.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 288.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 172.00 |
| 10 | Charles River Laboratories International | 14.28 Bn | 14.09 Bn | 452.07 Mn | -162.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -162.00 |
| Dec 27, 2025 | -796.00 |
| Sep 27, 2025 | -36.00 |
| Jun 28, 2025 | -474.00 |
| Mar 29, 2025 | -613.00 |
| Dec 28, 2024 | -4,222.00 |
| Sep 28, 2024 | -196.00 |
| Jun 29, 2024 | -48.00 |
| Mar 30, 2024 | -294.00 |
| Dec 30, 2023 | -168.00 |
| Sep 30, 2023 | -145.00 |
| Jul 1, 2023 | -267.00 |
| Apr 1, 2023 | 60.00 |
| Dec 31, 2022 | 419.00 |
| Sep 24, 2022 | -131.00 |
| Jun 25, 2022 | 87.00 |
| Mar 26, 2022 | 409.00 |
| Dec 25, 2021 | -372.00 |
| Sep 25, 2021 | -444.00 |
| Jun 26, 2021 | 164.00 |